COLCHICINE OPOCALCIUM 1 mg, comprimé sécable
APHP211055
Phase 3 small_molecule active
Quick answer
COLCHICINE OPOCALCIUM 1 mg, comprimé sécable for Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial Infarction, Coronary Syndrome, Cerebral Infarction is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial Infarction, Coronary Syndrome, Cerebral Infarction
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active